Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Kumar, Narender

  • Google
  • 2
  • 8
  • 15

Wellcome Sanger Institute

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2023A multipurpose ‘CZL’ vaginal ring for non-hormonal contraception and STI/HIV preventioncitations
  • 2020Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes15citations

Places of action

Chart of shared publication
Singer, Patrick
1 / 2 shared
Boyd, Peter
1 / 16 shared
Zhao, Xinyu
1 / 1 shared
Shen, Xin
1 / 1 shared
Lamb, Dolores
1 / 1 shared
Malcolm, Karl
1 / 21 shared
Mitchell, Lyann
1 / 1 shared
Mccoy, Clare
1 / 12 shared
Chart of publication period
2023
2020

Co-Authors (by relevance)

  • Singer, Patrick
  • Boyd, Peter
  • Zhao, Xinyu
  • Shen, Xin
  • Lamb, Dolores
  • Malcolm, Karl
  • Mitchell, Lyann
  • Mccoy, Clare
OrganizationsLocationPeople

document

A multipurpose ‘CZL’ vaginal ring for non-hormonal contraception and STI/HIV prevention

  • Singer, Patrick
  • Boyd, Peter
  • Zhao, Xinyu
  • Shen, Xin
  • Lamb, Dolores
  • Malcolm, Karl
  • Mitchell, Lyann
  • Mccoy, Clare
  • Kumar, Narender
Abstract

Marketed contraceptive intravaginal vaginal rings (IVR) rely upon sustained/controlled release of either a progestin (e.g., Progering®)or a progestin/estrogen combination (e.g., NuvaRing®, Annovera®). Here we report formulation development and testing of a new non-hormonal multipurpose IVR incorporating three actives – copper sulphate anhydrous (CSA), zinc lactate anhydrous (ZLA), and lactide (L; hydrolyses to lactic acid, LA) (aka. ‘CZL’ IVR) – and offering spermicidal, antibacterial and antiviral activity. Matrix-type silicone elastomer IVRs containing 30%CSA, 30%L, 10%CSA+20%L, 10%CSA+10%ZLA+10%L, and 10%CSA+10%ZLA+20%Lwere prepared by mixing the various actives with a medical-grade addition-cure silicone elastomer and injecting/curing the mixes at 115°C using custom molds. VRs were tested for weight, dimensions (outer and cross-sectional diameter), thermal behaviour (via DSC and TGA), in vitro release (deionised water, 37 °C ), pH reduction, and mechanical properties.All IVR formulations were successfully manufactured, producing VRs of well-defined dimensions (~57.4 x ~7.3 mm), ring weights that varied with type, quantity and combinationof actives (7.8–9.3 g), and mechanical properties similar to marketed IVR products (20 mm compression force and Shore M hardness values ranged 0.8–4.3 N and 41–67, respectively). The actives were not impacted by the VR manufacturing process, as evidenced by DSC and TGA data. Sustained and continuous release of copper and zinc ions (2–31 and 1–17 mg/day) and lactide/lactic acid (11–86 mg/day) was observed for all IVRs over 30 days; these values are considered in the ballpark for clinical efficacy based on in vitro sperm motility/antibacterial/antiviral data (see other poster). IVRs containing lactide maintained pH of the release medium within the range 2.2–4.6, consistent with (i) release of lactide and rapid hydrolysis to lactic acid and (ii) the pH modulating effects associated with CSA and ZLA. The data support the continued development of the multipurpose CZL IVR concept.<br/><br/>

Topics
  • zinc
  • hardness
  • copper
  • thermogravimetry
  • differential scanning calorimetry
  • curing
  • elastomer